Talphera (TLPH) Long-Term Debt Repayments (2010 - 2023)
Talphera (TLPH) posted quarterly Long-Term Debt Repayments of $3.3 million for Q2 2023, up 60.01% year-over-year from $2.1 million in Q2 2022, and up 60.01% quarter-over-quarter from $2.1 million in Q1 2023.
Talphera (TLPH) Long-Term Debt Repayments (2010 - 2023) Analysis & Trends
Talphera's Long-Term Debt Repayments history runs 10 years deep, the most recent figure standing at $3.3 million for Q2 2023.
- In Q2 2023, Long-Term Debt Repayments rose 60.01% year-over-year to $3.3 million; the TTM figure through Mar 2024 stood at $3.3 million (down 60.48% YoY), while the FY2023 annual figure was $5.4 million, down 35.78% from the prior year.
- Long-Term Debt Repayments for Q2 2023 stood at $3.3 million, up from $2.1 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $3.3 million in Q2 2023, with the low at $1.4 million in Q2 2019.
- The 5-year median for Long-Term Debt Repayments is $2.1 million (2020), against an average of $2.2 million.
- The sharpest annual moves came in 2019 and 2023: Long-Term Debt Repayments dropped 25.96% in 2019, then jumped 60.01% in 2023.
- Talphera's Long-Term Debt Repayments stood at $1.4 million in 2019, then soared by 48.22% to $2.1 million in 2020, then declined by 0.05% to $2.1 million in 2021, then rose by 4.8% to $2.2 million in 2022, then surged by 52.68% to $3.3 million in 2023.
- Business Quant data shows TLPH's Long-Term Debt Repayments at $3.3 million in Q2 2023, $2.1 million in Q1 2023, and $2.2 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -156,847.56 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 3.33 Mn |
| Mar 31, 2023 | 2.08 Mn |
| Mar 31, 2023 | 2.08 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Dec 31, 2022 | 2.18 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Sep 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Sep 30, 2021 | 2.58 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |